Abbott Laboratories (ABT)
CIK 1800 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Abbott Laboratories.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 3, 2026 | 4 | 0001644207-26-000012 |
| Sep 3, 2026 | 4 | 0001805099-26-000008 |
| Sep 2, 2026 | 144 | 0001644207-26-000010 |
| Aug 27, 2026 | 4 | 0001612571-26-000011 |
| Aug 25, 2026 | 144 | 0001612571-26-000008 |
| Aug 20, 2026 | 8-K | 0001104659-26-099247 |
| Aug 13, 2026 | 4 | 0001867666-26-000013 |
| Aug 11, 2026 | 144 | 0001867666-26-000011 |
| Jul 28, 2026 | 10-Q | 0001628280-26-050134 |
| Jul 16, 2026 | 8-K | 0001628280-26-048377 |
| Jul 1, 2026 | 4 | 0001577544-26-000010 |
| Jul 1, 2026 | 4 | 0001867666-26-000009 |
| Jul 1, 2026 | 4 | 0002102715-26-000006 |
| Jul 1, 2026 | 4 | 0001879701-26-000008 |
| Jul 1, 2026 | 4 | 0001385262-26-000019 |
| Jul 1, 2026 | 4 | 0001306119-26-000006 |
| Jun 29, 2026 | 4 | 0002075371-26-000009 |
| Jun 18, 2026 | 11-K | 0001104659-26-075724 |
| Jun 18, 2026 | 4 | 0001385262-26-000017 |
| May 27, 2026 | SD | 0001104659-26-066986 |
| May 15, 2026 | 144 | 0001448074-26-000012 |
| Apr 29, 2026 | SCHEDULE 13G | 0002100119-26-000151 |
| Apr 29, 2026 | 4 | 0001783147-26-000009 |
| Apr 29, 2026 | 10-Q | 0001628280-26-028357 |
| Apr 28, 2026 | 4 | 0001577544-26-000006 |